The umbilical cord (UC) matrix is a source of multipotent mesenchymal stem cells (MSCs) that have adipogenic potential and thus can be a model to study adipogenesis. However, existing variability in adipocytic differentiation outcomes may be due to discrepancies in methods utilized for adipogenic differentiation. Additionally, functional characterization of UCMSCs as adipocytes has not been described. We tested the potential of three well-established adipogenic cocktails containing IBMX, dexamethasone, and insulin (MDI) plus indomethacin (MDI-I) or rosiglitazone (MDI-R) to stimulate adipocyte differentiation in UCMSCs. MDI, MDI-I, and MDI-R treatment significantly increased peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT-enhancer binding protein alpha (C/EBPα) mRNA and induced lipid droplet formation. However, MDI-I had the greatest impact on mRNA expression of PPARγ, C/EBPα, FABP4, GPD1, PLIN1, PLIN2, and ADIPOQ and lipid accumulation, whereas MDI showed the least. Interestingly, there were no treatment group differences in the amount of PPARγ protein. However, MDI-I treated cells had significantly more C/EBPα protein compared to MDI or MDI-R, suggesting that indomethacin-dependent increased C/EBPα may contribute to the adipogenesis-inducing potency of MDI-I. Additionally, bone morphogenetic protein 4 (BMP4) treatment of UCMSCs did not enhance responsiveness to MDI-induced differentiation. Finally to characterize adipocyte function, differentiated UCMSCs were stimulated with insulin and downstream signaling was assessed. Differentiated UCMSCs were responsive to insulin at two weeks but showed decreased sensitivity by five weeks following differentiation, suggesting that long-term differentiation may induce insulin resistance. Together, these data indicate that UCMSCs undergo adipogenesis when differentiated in MDI, MDI-I, and MDI-R, however the presence of indomethacin greatly enhances their adipogenic potential beyond that of rosiglitazone. Furthermore, our results suggest that insulin signaling pathways of differentiated UCMSCs are functionally similar to adipocytes.
TsagiasNKoliakosIKaragiannisVEleftheriadouMKoliakosGG. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes. Transfus Med2011; 21: 253–61.
2.
WeissMLMedicettySBledsoeARRachakatlaRSChoiMMerchavSLuoYRaoMSVelagaletiGTroyerD. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells2006; 24: 781–92.
3.
YanMSunMZhouYWangWHeZTangDLuSWangXLiSLiH. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model. PLoS One2013; 8: e64000–e64000.
4.
NekantiUMohantyLVenugopalPBalasubramanianSToteySTaM. Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res2010; 5: 244–254.
5.
NekantiURaoVBBahirvaniAGJanMToteySTaM. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev2010; 19: 117–30.
6.
HanYChaiJSunTLiDTaoR. Differentiation of human umbilical cord mesenchymal stem cells into dermal fibroblasts in vitro. Biochem Biophys Res Commun2011; 413: 561–5.
7.
KarahuseyinogluSCinarOKilicEKaraFAkayGGDemiralpDOTukunAUckanDCanA. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys. Stem Cells2007; 25: 319–31.
8.
WangHSHungSCPengSTHuangCCWeiHMGuoYJFuYSLaiMCChenCC. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells2004; 22: 1330–7.
9.
EspositoMLucarielloACostanzoCFiumarellaAGianniniARiccardiGRiccioI. Differentiation of human umbilical cord-derived mesenchymal stem cells, WJ-MSCs, into chondrogenic cells in the presence of pulsed electromagnetic fields. In Vivo2013; 27: 495–500.
10.
ConconiMTBurraPDi LiddoRCaloreCTurettaMBelliniSBoPNussdorferGGParnigottoPP. CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med2006; 18: 1089–96.
11.
ZeddouMBriquetARelicBJosseCMalaiseMGGothotALechanteurCBeguinY. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int2010; 34: 693–701.
12.
AnzaloneRLo IaconoMCorraoSMagnoFLoriaTCappelloFZummoGFarinaFLa RoccaG. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev2010; 19: 423–38.
13.
Ma L, Feng XY, Cui BL, Law F, Jiang XW, Yang LY, Xie QD, Huang TH. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chin Med J (Engl) 118:1987–93.
14.
MitchellKEWeissMLMitchellBMMartinPDavisDMoralesLHelwigBBeerenstrauchMAbou-EasaKHildrethTTroyerDMedicettyS. 2003 Matrix cells from Wharton's jelly form neurons and glia. Stem Cells2005; 21: 50–60.
15.
JoCHKimOSParkEYKimBJLeeJHKangSBHanHSRheeSHYoonKS. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion. Cell Tissue Res2008; 334: 423–33.
16.
DorronsoroARobbinsPD. Regenerating the injured kidney with human umbilical cord mesenchymal stem cell-derived exosomes. Stem Cell Res Ther2013; 4: 39–39.
17.
LiTYanYWangBQianHZhangXShenLWangMZhouYZhuWLiWXuW. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev2013; 22: 845–54.
18.
BaysHEGonzalez-CampoyJMBrayGAKitabchiAEBergmanDASchorrABRodbardHWHenryRR. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther2008; 6: 343–68.
19.
HoffstedtJArnerEWahrenbergHAnderssonDPQvisthVLofgrenPRydenMThorneAWirenMPalmerMThorellAToftEArnerP. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia2010; 53: 2496–503.
20.
TangQQLaneMD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem2012; 81: 715–36.
21.
CristanchoAGLazarMA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol2011; 12: 722–34.
22.
CorneliusPMacDougaldOALaneMD. Regulation of adipocyte development. Annu Rev Nutr1994; 14: 99–129.
23.
MacDougaldOALaneMD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem1995; 64: 345–73.
ScottMANguyenVTLeviBJamesAW. Current methods of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev2011; 20: 1793–804.
26.
PengKWLiouYM. Differential role of actin-binding proteins in controlling the adipogenic differentiation of human CD105-positive Wharton's Jelly cells. Biochim Biophys Acta2012; 1820: 469–81.
27.
RagniEViganoMParazziVMontemurroTMontelaticiELavazzaCBudelliSVecchiniARebullaPGiordanoRLazzariL. Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest. Int J Biochem Cell Biol2013; 45: 2456–66.
28.
KimDWStaplesMShinozukaKPantchevaPKangSDBorlonganCV. Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci2013; 14: 11692–712.
29.
CiavarellaSDammaccoFDe MatteoMLoverroGSilvestrisF. Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts. Stem Cells Dev2009; 18: 1211–20.
30.
RosenEDWalkeyCJPuigserverPSpiegelmanBM. Transcriptional regulation of adipogenesis. Genes Dev2000; 14: 1293–307.
31.
StynerMSenBXieZCaseNRubinJ. Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism. J Cell Biochem2010; 111: 1042–50.
32.
WangDHaileAJonesLC. Rosiglitazone-induced adipogenesis in a bone marrow mesenchymal stem cell line - biomed 2011. Biomed Sci Instrum2011; 47: 213–21.
33.
BenvenutiSCellaiILucianiPDeleddaCBaglioniSGiulianiCSaccardiRMazzantiBDal PozzoSMannucciEPeriASerioM. Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J Endocrinol Invest2007; 30: RC26–30.
34.
WeltersHJEl OuaamariAKawamoriDMeyerJHuJSmithDMKulkarniRN. Rosiglitazone promotes PPARgamma-dependent and -independent alterations in gene expression in mouse islets. Endocrinology2012; 153: 4593–9.
35.
HuangHSongTJLiXHuLHeQLiuMLaneMDTangQQ. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A2009; 106: 12670–5.
36.
SeshareddyKTroyerDWeissML. Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol2008; 86: 101–19.
37.
SabenJZhongYGomez-AcevedoHThakaliKMBorengasserSJAndresAShankarK. Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity. Am J Physiol Endocrinol Metab2013; 305: E1–14.
38.
LazarDFWieseRJBradyMJMastickCCWatersSBYamauchiKPessinJECuatrecasasPSaltielAR. Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem1995; 270: 20801–7.
39.
LeeYHGiraudJDavisRJWhiteMF. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem2003; 278: 2896–902.
40.
LuLLLiuYJYangSGZhaoQJWangXGongWHanZBXuZSLuYXLiuDChenZZHanZC. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica2006; 91: 1017–26.
41.
CiavarellaSDammaccoFDe MatteoMLoverroGSilvestrisF. Umbilical cord mesenchymal stem cells: role of regulatory genes in their differentiation to osteoblasts. Stem Cells Dev2009; 18: 1211–20.
42.
BoschJHoubenAPRadkeTFStapelkampDBunemannEBalanPBuchheiserALiedtkeSKoglerG. Distinct differentiation potential of “MSC” derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?Stem Cells Dev2012; 21: 1977–88.
DingJNagaiKWooJT. Insulin-dependent adipogenesis in stromal ST2 cells derived from murine bone marrow. Biosci Biotechnol Biochem2003; 67: 314–21.
45.
TangQQOttoTCLaneMD. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci U S A2004; 101: 9607–11.
46.
HammarstedtAHedjazifarSJenndahlLGoggSGrunbergJGustafsonBKlimcakovaEStichVLanginDLaaksoMSmithU. WISP2 regulates preadipocyte commitment and PPARgamma activation by BMP4. Proc Natl Acad Sci U S A2013; 110: 2563–8.
47.
BowersRRKimJWOttoTCLaneMD. Stable stem cell commitment to the adipocyte lineage by inhibition of DNA methylation: role of the BMP-4 gene. Proc Natl Acad Sci U S A2006; 103: 13022–7.
48.
GuptaRKAranyZSealePMepaniRJYeLConroeHMRobyYAKulagaHReedRRSpiegelmanBM. Transcriptional control of preadipocyte determination by Zfp423. Nature2010; 464: 619–23.
49.
FreytagSOPaielliDLGilbertJD. Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev1994; 8: 1654–63.
50.
LinFTLaneMD. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci U S A1994; 13: 8757–61.
51.
RosenEDSpiegelmanBM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol2000; 16: 145–71.
52.
RicortJMTantiJFVan ObberghenEMarchand-BrustelY. Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia1995; 38: 1148–56.
53.
WuZRosenEDBrunRHauserSAdelmantGTroyAEMcKeonCDarlingtonGJSpiegelmanBM. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell1999; 3: 151–8.
54.
GeXYuQQiWShiXZhaiQ. Chronic insulin treatment causes insulin resistance in 3T3-L1 adipocytes through oxidative stress. Free Radic Res2008; 42: 582–91.
55.
BasivireddyJVasudevanAJacobMBalasubramanianKA. Indomethacin-induced mitochondrial dysfunction and oxidative stress in villus enterocytes. Biochem Pharmacol2002; 64: 339–49.
56.
HiguchiMDustingGJPeshavariyaHJiangFHsiaoSTChanECLiuGS. Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes. Stem Cells Dev2013; 22: 878–88.
57.
TaniguchiCMEmanuelliBKahnCR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol2006; 7: 85–96.
58.
PorrasASantosE. The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade. Int J Obes Relat Metab Disord1996; 20: S43–51.
59.
AguirreVUchidaTYenushLDavisRWhiteMF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem2000; 275: 9047–54.
60.
NguyenMTSatohHFavelyukisSBabendureJLImamuraTSbodioJIZalevskyJDahiyatBIChiNWOlefskyJM. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem2005; 280: 35361–71.
61.
EvansJLGoldfineIDMadduxBAGrodskyGM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?Diabetes2003; 52: 1–8.
